Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 2033-2040
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.2033
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.2033
Figure 4 Hepatobiliary enhanced magnetic resonance imaging after two cycles of targeted immunotherapy.
A: Right epigastric metastases size of 0.4 cm × 0.5 cm (orange circle); B: Liver metastases in S5 segment size of 1.8 cm × 1.7 cm (blue circle); C: Left lateral lobe of the livermetastasis size of 0.9 cm × 0.9 cm (blue circle); D: Carcinoma in the middle and lower segment of the common bile duct size of 1.1 cm (orange circle); E: Retroperitoneal enlarged lymph nodes size of 1.3 cm (orange circle).
- Citation: Luo WH, Li SJ, Wang XF. Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature. World J Gastrointest Oncol 2023; 15(11): 2033-2040
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/2033.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.2033